|

SHARP SYMPTOM. Medical workers check on patients in Jinyintan
Hospital, designated for critical condition COVID-19 patients, in Wuhan,
central China’s Hubei province, in this February 13, 2020 file photo.
COVID-19 variant NB.1.8.1., or "Nimbus," may be driving a rise in cases
in some parts of the world that has earned it a new nickname — "razor
blade throat" COVID — because the variant may cause painful sore
throats. (Chinatopix Via AP, File)
From The Asian Reporter, V35, #7 (July 7, 2025), page 9.
What to know about the COVID variant that may cause
"razor blade" sore throats
By Devi Shastri
AP Health Writer
The COVID-19 variant that may be driving a recent rise in cases in
some parts of the world has earned a new nickname: "razor blade throat"
COVID.
That’s because the variant — NB.1.8.1. or "Nimbus" — may cause
painful sore throats. The symptom has been identified by doctors in the
United Kingdom, India, and elsewhere, according to media outlets in
those countries.
Other COVID-19 symptoms of any variant include fever, chills, cough,
shortness of breath, or loss of taste or smell.
Experts say there isn’t major cause for concern with the Nimbus
variant, but here’s what else you need to know about it.
Here’s where the variant causing "razor blade throat"
is spreading
The rise in cases in late May was primarily in eastern Mediterranean,
Southeast Asia, and western Pacific regions, the World Health
Organization (WHO) said. The new variant had reached nearly 11% of
sequenced samples reported globally in mid-May.
Airport screening in the United States detected the new variant in
travellers arriving from those regions to destinations in California,
Washington state, Virginia, and New York.
You aren’t likely to get sicker from this variant than
others
Not so far, anyway.
WHO said some western Pacific countries had reported increases in
COVID cases and hospitalizations, but there’s nothing so far to suggest
that the disease associated with the new variant is more severe compared
to other variants.
COVID-19 vaccines are effective against the Nimbus
variant
Yes.
WHO has designated Nimbus as a "variant under monitoring" and
considers the public health risk low at the global level. Current
vaccines are expected to remain effective.
Health Secretary Robert F. Kennedy Jr. announced in May that COVID-19
shots are no longer recommended for healthy children and pregnant women
— a move immediately questioned by public health experts.
AP Health Writer Carla Johnson contributed to this story. The
Associated Press Health and
Science Department receives support from the Howard Hughes Medical
Institute’s Science and Educational Media Group and the Robert Wood
Johnson Foundation. The AP is solely responsible for content.
* * *
Read the current issue of The Asian Reporter in
its entirety!
Just visit <www.asianreporter.com/completepaper.htm>!
|